Astonea Labs: No Deviation in IPO Fund Utilization for H1 FY27

Astonea Labs Limited has confirmed that there has been no deviation or variation in the utilization of funds raised through its Initial Public Offering (IPO). This confirmation pertains to the half-year period ended September 30, 2026. The company stated that the Statement of Deviation or Variation for this period is NIL, adhering to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing details the original objects of the issue, including funding expenses for registration in Bolivia, purchase of plant and machinery for ointment production, advertising, marketing, brand building, procurement of hardware and software, working capital, and general corporate purposes. The total IPO amount raised was ₹37,66,50,000.